NIH-funded research R01 grant

Fibrinolytic and inflammatory drivers of severe trauma outcomes

Official title: Unraveling the Role of The Fibrinolytic-Inflammatory Axis in Severe Trauma Adverse Outcomes: From Acute Organ Dysfunction to Chronic Disability

Funded at Vanderbilt University Medical Center · NIH-11400058 · Data updated 2026-11-12

This grant looks at how the body's clot-busting system and immune cells interact after severe trauma to influence early organ failure and long-term disability.

More Disability research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionVanderbilt University Medical Center
NIH-funded
Lab location1 site (Nashville, United States)
Project startSeptember 1, 2025
Project endJune 30, 2029
Funding year2026
Award (this year)$435,510
NIH project number5R01GM157158-02
Project IDNIH-11400058 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are patients who have survived a severe traumatic injury and are at risk for acute organ dysfunction or chronic post-injury symptoms, relevant to future translational work.

Less likely to help

Trauma patients who do not experience the inflammatory cascade described or those not proceeding to translation may see minimal direct benefit.

What this research studies

Researchers will study how the fibrinolytic system and innate immune cells like neutrophils and macrophages change after severe trauma in a mouse model. They will use advanced immune cell profiling and tissue analysis to map the sequence of events from early hyperfibrinolysis to late chronic inflammation. The goal is to understand how this progression leads to ongoing organ damage and pain, with the aim of identifying points where treatment could improve recovery.

Why it matters

Potential benefit: If successful, the work could reveal new targets to prevent long-term complications after severe trauma and improve survival and quality of life.

How similar studies have gone: Similar studies in animal models have begun to map immune responses after trauma, but translating these findings to human outcomes remains a key challenge.

Where this research is happening

  • Vanderbilt University Medical Center
    Nashville, United States
    Active

Researchers

  • Principal investigator: Schoenecker, Jonathan — Vanderbilt University Medical Center
  • Study coordinator: Schoenecker, Jonathan

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.